Product Highlight - Replagal

Active ingredient: Agalsidase alfa

Indication: Long-term enzyme replacement therapy in patients with confirmed diagnosis of Fabry Disease (α-galactosidase A deficiency).

Dosage & Administration: 0.2 mg/kg every other week via intravenous infusion over 40 minutes.